Search global stocks & ETFs...Ctrl K
Learn Mode
PGNY
Stock Profile
08-05
Recommended Metric
Score Card
Explore Scores Tab
3.88
Good
Valuation Model
Key Score
3.00
Average
Management
3.00
Average
Growth
4.00
Good
Profitability
4.00
Good
Fin. Health
3.00
Average
Dividends
--
--
Analyst
5.00
Very Good
Insider Transactions
Explore Insider Tab ›Buy Transactions
Sell Transactions
Peers
Select stocks to compare
Price Targets & Ratings
View Analysis
1-year price targets, ending May 11, 2027
Current
$25.86
Baseline
High
$32.55
▲
25.87%
Avg
$28.75
▲
11.16%
Low
$19.19
▼
-25.79%
Analyst Ratings based on 17 Analysts
Strong Buy
635%
Buy
953%
Hold
212%
Sell
000%
Strong Sell
000%
Progyny, Inc. is a fertility benefits management company. The company is headquartered in New York City, New York and currently employs 856 full-time employees. The company went IPO on 2019-10-25. The firm specializes in fertility and family building benefits solutions in the United States. The Company’s clients include various employers across an array of industries. The company has contracts to provide coverage to approximately 6.7 million employees and their partners (known as members). The firm provides its benefits through its proprietary Smart Cycle approach. Smart Cycles include the medical services required for a member’s full course of treatment, including all necessary diagnostic testing and access to the technology. In addition to its fertility benefits solution, the Company offers an integrated pharmacy benefits solution, Progyny Rx, which can be added by its clients. Progyny Rx provides its members with access to the medications needed during their fertility treatment. The company provides care management services, as well as medication administration training, pharmacy support services and continuing patient care advocate support.Read More
Stock News
View All Updates
News75%Bullish
Progyny Inc (NASDAQ:PGNY) Screens Well on Caviar Cruise Quality Investing Metrics
6hChartMill
B of A Securities Maintains Buy on Progyny, Raises Price Target to $31
4dBenzinga
3 Cash-Heavy Stocks That Concern Us
4dYahoo
A Progyny (PGNY) Insider Sold 5,500 Shares for $137,000
6dYahoo
New Progyny Study Shows Growing Demand for Human Guidance in an Increasingly Digital Healthcare System
1wYahoo
Progynyn (NASDAQ:PGNY): A Bull Flag Breakout with Strong Fundamentals
1wChartMill
Progyny, Inc. Announces Share Repurchase Program
1wYahoo
Progyny (PGNY) Is Up 7.0% After Analyst Upgrade Backed By Six Earnings Beats And 2026 Outlook
1wYahoo
3 Stocks Under $50 with Warning Signs
2wYahoo
Progyny, Inc. (PGNY) Shareholder/Analyst Call Transcript
2wSeekingAlpha
Progyny (PGNY) Stock Is Up, What You Need To Know
2wYahoo
StubHub, Jazz Pharmaceuticals upgraded: Wall Street's top analyst calls
2wYahoo
This Stubhub Analyst Turns Bullish; Here Are Top 4 Upgrades For Tuesday
2wBenzinga
Canaccord Genuity Upgrades Progyny to Buy, Raises Price Target to $30
2wBenzinga
Progyny and Standex International have been highlighted as Zacks Bull and Bear of the Day
2wYahoo
Barclays Maintains Overweight on Progyny, Raises Price Target to $27
2wBenzinga
Bull of the Day: Progyny (PGNY)
2wYahoo
Progyny’s Q1 Earnings Call: Our Top 5 Analyst Questions
2wYahoo
Shareholders Will Be Pleased With The Quality of Progyny's (NASDAQ:PGNY) Earnings
3wYahoo
Progyny Inc (NASDAQ:PGNY): A GARP Play with Balanced Growth and Valuation
3wChartMill
3 Small-Cap Stocks with Open Questions
3wYahoo
Why Is Progyny (PGNY) Stock Soaring Today
3wYahoo
Progyny, Inc. (PGNY) Presents at Bank of America Global Healthcare Conference 2026 Transcript
3wSeekingAlpha
Transcript : Progyny, Inc. Presents at Bank of America Global Healthcare Conference 2026, May-12-2026 11
3wFinnhub
Progyny, Inc. to Present at BofA Securities 2026 Health Care Conference
3wYahoo
Truist Securities Maintains Buy on Progyny, Raises Price Target to $30
3wBenzinga
Citizens Maintains Market Outperform on Progyny, Raises Price Target to $31
3wBenzinga
A Look At Progyny (PGNY) Valuation After Raised Guidance And Share Repurchase
3wYahoo
Progyny, Inc. 2026 Q1 - Results - Earnings Call Presentation
4wSeekingAlpha
Progyny Q1 Earnings Call Highlights
4wYahoo
Fertility Benefits Growth and Share Buybacks Keep Progyny (PGNY) Earnings in Focus
4wYahoo
12 Health Care Stocks Moving In Friday's Pre-Market Session
4wBenzinga
Progyny, Inc. (PGNY) Q1 2026 Earnings Call Transcript
4wSeekingAlpha
Transcript : Progyny, Inc., Q1 2026 Earnings Call, May 07, 2026
4wFinnhub
Progyny, Inc. Q1 2026 Earnings Call Summary
4wYahoo
Progyny (PGNY) Q1 Earnings and Revenues Beat Estimates
4wYahoo
Progyny Inc (NASDAQ:PGNY) Beats Q1 Estimates and Guides Above Consensus as Selling Season Off to a Strong Start
4wChartMill
Progyny: Q1 Earnings Snapshot
4wFinnhub
12 Health Care Stocks Moving In Thursday's After-Market Session
4wBenzinga
Progyny Sees Q2 GAAP EPS $0.31-$0.35 vs $0.30 Est
4wBenzinga
Progyny Sees Q2 Adj EPS $0.50-$0.53 vs $0.33 Est; Sees Sales $342.000M-$355.000M vs $347.385M Est
4wBenzinga
Progyny Raises FY2026 GAAP EPS Guidance from $1.10-$1.22 to $1.23-$1.34 vs $1.18 Est
4wBenzinga
Progyny Raises FY2026 Adj EPS Guidance from $1.83-$1.95 to $1.98-$2.09 vs $1.32 Est; Raises FY2026 Sales Guidance from $1.355B-$1.405B to $1.365B-$1.405B vs $1.376B Est
4wBenzinga
Progyny Q1 Adj. EPS $0.50 Beats $0.30 Estimate, Sales $328.504M Beat $326.514M Estimate
4wBenzinga
Progyny, Inc. Announces Details for Its First Quarter 2026 Results Report
6wFinnhub
Progyny: Significant Non-Cash Compensation Limits Value Case
6wSeekingAlpha
Progyny Expands Access to Fertility and Women's Health with Industry's First Fully Insured Supplemental Plan
7wFinnhub
Progyny Launches Progyny Select, The Industry's First Fully Insured, Comprehensive Supplemental Fertility And Family Building Plan
7wBenzinga
Progyny Expands Access to Fertility and Women’s Health with Industry’s First Fully Insured Supplemental Plan
7wFinnhub
Joi + Blokes Expands Platform with Fertility Division Led by Serial Founder Gina Bartasi
10wYahoo